Neuromodulation versus neurotoxin for the treatment of refractory detrusor overactivity: For neuromodulation

Nature Clinical Practice Urology

Volumn 5, Issue 3, 2008, Pages 118-119

  Nakib, Nissrine ^a   Siegel, Steven ^a  

^a Center for Continence Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; NEUROTOXIN;

ARTICLE; CATHETERIZATION; CLINICAL TRIAL; DETRUSOR MUSCLE; DRUG INDICATION; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; INDIVIDUALIZATION; LUMBOSACRAL PLEXUS; NERVE STIMULATION; NEUROMODULATION; OVERACTIVE BLADDER; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; REIMBURSEMENT; REOPERATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION;

ANIMALS; HUMANS; LUMBOSACRAL PLEXUS; NEUROTOXINS; NEUROTRANSMITTER AGENTS; URINARY BLADDER, OVERACTIVE;

EID: 40749141134     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1033     Document Type: Article

References (9)

1. Bernstein AJ and Peters KM (2005) Expanding indications for neuromodulation. Urol Clin North Am 32: 59-63
2. Medtronic Inc. website [http://wwwp.medtronic.com/Newsroom/ NewsReleaseDetails.do?itemld=1193922073226&lang=en_US] (accessed 17 December 2007)
3. Brazzelli M et al. (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: A systematic review. J Urol 175: 835-841
4. Hassouna MM et al. (2000) Sacral neuromodulation in the treatment of urgency-frequency symptoms: A multicenter study on efficacy and safety. J Urol 163: 1849-1854
5. Jonas U et al. (2001) Efficacy of sacral nerve stimulation for urinary retention: Results 18 months after implantation. J Urol 165: 15-19
6. van Kerrebroeck PE et al. (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: Outcomes of a prospective, worldwide clinical study. J Urol 178: 2029-2034
7. Lemack GE et al. (2007) Highlights from the combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation annual meeting. J Urol 177: 691-695
8. Van Voskuilen AC et al. (2007) Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int 99 107-110
9. Borawski KM et al. (2007) Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourol Urodyn 26: 14-18